A detailed history of Albion Financial Group transactions in Viatris Inc stock. As of the latest transaction made, Albion Financial Group holds 86 shares of VTRS stock, worth $893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86
Holding current value
$893
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$8.74 - $10.69 $751 - $919
86 New
86 $0
Q2 2022

Jul 29, 2022

SELL
$9.95 - $12.27 $9 - $12
-1 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$12.09 - $14.68 $1,789 - $2,172
-148 Reduced 99.33%
1 $0
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $1,297 - $1,614
-100 Reduced 40.16%
149 $2,000
Q4 2020

Feb 19, 2021

BUY
$14.3 - $18.74 $3,560 - $4,666
249 New
249 $5,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.